115 related articles for article (PubMed ID: 21595277)
1. [Clinical application of exenatide in Japanese patients with type 2 diabetes mellitus].
Toyonaga T; Araki E
Nihon Rinsho; 2011 May; 69(5):890-4. PubMed ID: 21595277
[TBL] [Abstract][Full Text] [Related]
2. [Exenatide--an alternative to insulin in the treatment of type 2 diabetes?].
Kjeldsen R; Sandbaek A
Ugeskr Laeger; 2008 Sep; 170(39):3039-43. PubMed ID: 18822227
[TBL] [Abstract][Full Text] [Related]
3. Exenatide: clinical aspects of the first incretin-mimetic for the treatment of type 2 diabetes mellitus.
Wajcberg E; Tavaria A
Expert Opin Pharmacother; 2009 Jan; 10(1):135-42. PubMed ID: 19236187
[TBL] [Abstract][Full Text] [Related]
4. Exenatide exhibits dose-dependent effects on glycemic control over 12 weeks in Japanese patients with suboptimally controlled type 2 diabetes.
Kadowaki T; Namba M; Yamamura A; Sowa H; Wolka AM; Brodows RG
Endocr J; 2009; 56(3):415-24. PubMed ID: 19194050
[TBL] [Abstract][Full Text] [Related]
5. [Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus].
Perusicová J
Vnitr Lek; 2008 Apr; 54(4):377-86. PubMed ID: 18630617
[TBL] [Abstract][Full Text] [Related]
6. [Exenatide trials for the treatment of type 2 diabetes].
Fernández Landó L; Casellini CM
Medicina (B Aires); 2009; 69(4):447-57. PubMed ID: 19770100
[TBL] [Abstract][Full Text] [Related]
7. Exenatide: a novel approach for treatment of type 2 diabetes.
Mikhail N
South Med J; 2006 Nov; 99(11):1271-9. PubMed ID: 17195423
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults.
Tzefos M; Harris K; Brackett A
Ann Pharmacother; 2012 Jan; 46(1):68-78. PubMed ID: 22232377
[TBL] [Abstract][Full Text] [Related]
9. An update on exenatide, a novel therapeutic option for patients with type 2 diabetes.
Crasto W; Khunti K; Davies MJ
Drugs Today (Barc); 2011 Nov; 47(11):839-56. PubMed ID: 22146227
[TBL] [Abstract][Full Text] [Related]
10. Exenatide once weekly in type 2 diabetes.
Scheen AJ
Lancet; 2008 Oct; 372(9645):1197-8. PubMed ID: 18782642
[No Abstract] [Full Text] [Related]
11. Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data.
Gallwitz B
Int J Clin Pract; 2006 Dec; 60(12):1654-61. PubMed ID: 17109672
[TBL] [Abstract][Full Text] [Related]
12. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
Pinelli NR; Cha R; Brown MB; Jaber LA
Ann Pharmacother; 2008 Nov; 42(11):1541-51. PubMed ID: 18957626
[TBL] [Abstract][Full Text] [Related]
13. Exenatide: its position in the treatment of type 2 diabetes.
Guerci B; Martin CS
Ann Endocrinol (Paris); 2008 Jun; 69(3):201-9. PubMed ID: 18533126
[TBL] [Abstract][Full Text] [Related]
14. [Type 2 diabetic patient with reduced beta-cell function. New substance class: incretin-mimetics].
MMW Fortschr Med; 2005 Aug; 147(31-32):55. PubMed ID: 16128203
[No Abstract] [Full Text] [Related]
15. Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes.
Aroda VR; DeYoung MB
Postgrad Med; 2011 Sep; 123(5):228-38. PubMed ID: 21904106
[TBL] [Abstract][Full Text] [Related]
16. [Exenatide convinces in a six-month study: HbA1c sunk significantly].
MMW Fortschr Med; 2009 May; 151(19):51. PubMed ID: 19827448
[No Abstract] [Full Text] [Related]
17. Exenatide: excessive weight loss.
Prescrire Int; 2011 Jan; 20(112):17. PubMed ID: 21462789
[No Abstract] [Full Text] [Related]
18. Exenatide: a review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea).
Cvetković RS; Plosker GL
Drugs; 2007; 67(6):935-54. PubMed ID: 17428109
[TBL] [Abstract][Full Text] [Related]
19. Missing the point: substituting exenatide for nonoptimized insulin: going from bad to worse!
Rosenstock J; Fonseca V
Diabetes Care; 2007 Nov; 30(11):2972-3. PubMed ID: 17965313
[No Abstract] [Full Text] [Related]
20. Exenatide in combination therapy: small study, big market, and many unanswered questions.
Malozowski S
Ann Intern Med; 2007 Apr; 146(7):527-8. PubMed ID: 17404355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
